These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31567712)

  • 1. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Lou S; Watthanasuntorn K; Kroner PT; Cheungpasitporn W; Lukens FJ; Pungpapong S; Keaveny AP; Ungprasert P
    Eur J Gastroenterol Hepatol; 2020 May; 32(5):601-608. PubMed ID: 31567712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic Fatty Liver Disease and Urolithiasis. A Systematic Review and Meta-Analysis.
    Wijarnpreecha K; Lou S; Panjawatanan P; Sanguankeo A; Pungpapong S; Lukens FJ; Ungprasert P
    J Gastrointestin Liver Dis; 2018 Dec; 27(4):427-432. PubMed ID: 30574625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Thongprayoon C; Jaruvongvanich V; Ungprasert P
    Saudi J Gastroenterol; 2018; 24(1):12-17. PubMed ID: 29451179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Aby ES; Panjawatanan P; Lapumnuaypol K; Cheungpasitporn W; Lukens FJ; Harnois DM; Ungprasert P
    Ann Gastroenterol; 2021; 34(4):568-574. PubMed ID: 34276197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Boonpheng B; Panjawatanan P; Sharma K; Ungprasert P; Pungpapong S; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):986-994. PubMed ID: 29787418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents.
    Belei O; Olariu L; Dobrescu A; Marcovici T; Marginean O
    J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1161-1168. PubMed ID: 28988228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis.
    Kuang L; Zhou W; Jiang Y
    PLoS One; 2021; 16(12):e0260479. PubMed ID: 34855819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis.
    Wijarnpreecha K; Lou S; Panjawatanan P; Cheungpasitporn W; Pungpapong S; Lukens FJ; Ungprasert P
    Dig Liver Dis; 2018 Nov; 50(11):1166-1175. PubMed ID: 30292566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Meta-Analysis.
    Wijarnpreecha K; Werlang ME; Watthanasuntorn K; Panjawatanan P; Cheungpasitporn W; Gomez V; Lukens FJ; Ungprasert P
    Dig Dis Sci; 2020 May; 65(5):1414-1422. PubMed ID: 31605277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.
    Su T; Lai S; Lee A; He X; Chen S
    J Gastroenterol; 2018 Jan; 53(1):27-36. PubMed ID: 28770351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between gastroesophageal reflux disease and nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Thongprayoon C; Jaruvongvanich V; Ungprasert P
    Saudi J Gastroenterol; 2017; 23(6):311-317. PubMed ID: 29205182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association between Periodontitis and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Cheungpasitporn W; Lukens FJ; Harnois DM; Pungpapong S; Ungprasert P
    J Gastrointestin Liver Dis; 2020 Jun; 29(2):211-217. PubMed ID: 32530988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Kroner PT; Cheungpasitporn W; Ungprasert P
    Ann Gastroenterol; 2020; 33(6):661-666. PubMed ID: 33162743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth.
    Rafiei R; Bemanian M; Rafiei F; Bahrami M; Fooladi L; Ebrahimi G; Hemmat A; Torabi Z
    Rom J Intern Med; 2018 Jun; 56(2):85-89. PubMed ID: 29101772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis.
    Wijarnpreecha K; Boonpheng B; Thongprayoon C; Jaruvongvanich V; Ungprasert P
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):525-532. PubMed ID: 28866089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Lekuthai N; Thongprayoon C; Cheungpasitporn W; Ungprasert P
    Liver Int; 2017 Jun; 37(6):906-918. PubMed ID: 27891768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High parathyroid hormone level as a marker of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis.
    Jaroenlapnopparat A; Rittiphairoj T; Chaisidhivej N; Walker B; Charoenngam N
    Diabetes Metab Syndr; 2023 Aug; 17(8):102827. PubMed ID: 37451113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopause is associated with increased prevalence of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Jaroenlapnopparat A; Charoenngam N; Ponvilawan B; Mariano M; Thongpiya J; Yingchoncharoen P
    Menopause; 2023 Mar; 30(3):348-354. PubMed ID: 36728528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience.
    Fitriakusumah Y; Lesmana CRA; Bastian WP; Jasirwan COM; Hasan I; Simadibrata M; Kurniawan J; Sulaiman AS; Gani RA
    BMC Gastroenterol; 2019 Mar; 19(1):43. PubMed ID: 30894137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.